Early measurable residual disease detection post-haematopoietic stem cell transplantation in acute myeloid leukaemia

Background: Detection of measurable residual disease (MRD) is becoming the standard of care in the prognostication of acute myeloid leukaemia post-chemotherapy, but its role in early post-haematopoietic stem cell transplantation (HSCT) is less defined. Objectives: This study aims to examine the role...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sze P. Tsui, Stephen S. Y. Lam, Chun H. Au, Chi Y. Fung, Beca B. K. Ip, Anthony T. C. Wong, Henry C. M. Leung, Wing H. Lai, Ho W. Ip, Edmond S. K. Ma, Garret M. K. Leung, Joycelyn P. Y. Sim, Anskar Y. H. Leung
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publishing 2025-11-01
Serija:Therapeutic Advances in Hematology
Online pristup:https://doi.org/10.1177/20406207251389815
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items